Kathleen Moore to Clinical Trials, Phase I as Topic
This is a "connection" page, showing publications Kathleen Moore has written about Clinical Trials, Phase I as Topic.
Connection Strength
0.178
-
Post hoc analyses of GOG 9923: Does BRCA status affect toxicities?: An NRG oncology study. Gynecol Oncol. 2021 05; 161(2):512-515.
Score: 0.178